test

Nathalie Auber

@Sofinnova Investments, Inc.

Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.

Assets under management

The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TGTXTg Therapeutics Inc
Recent Activity
Decreased -80.73%
0.67%
$8.389M
358,644 shares@ $23.39 avg price
AVTEAerovate Therapeutics Inc
Recent Activity
0.63%
$7.856M
3.759M shares@ $2.1 avg price
ESTAEstablishment Labs Hldgs Inc
Recent Activity
Decreased -57.72%
0.63%
$7.852M
181,476 shares@ $43.28 avg price
MRNSMarinus Pharmaceuticals Inc
Recent Activity
Increased 3.06%
0.62%
$7.72M
4.386M shares@ $1.77 avg price
JANXJanux Therapeutics Inc
Recent Activity
New Position
0.6%
$7.486M
164,770 shares@ $45.43 avg price
CABACabaletta Bio Inc
Recent Activity
Increased 25.69%
0.58%
$7.24M
1.534M shares@ $4.73 avg price
ACHVAchieve Life Sciences Inc
Recent Activity
Increased 9.06%
0.57%
$7.177M
1.514M shares@ $4.75 avg price
KURAKura Oncology Inc
Recent Activity
Decreased -64.02%
0.47%
$5.801M
296,884 shares@ $19.54 avg price
PAHCPhibro Animal Health Corp
Recent Activity
Increased 0.5%
0.43%
$5.364M
238,184 shares@ $22.53 avg price
ILMNIllumina Inc
Recent Activity
New Position
0.43%
$5.296M
40,611 shares@ $130.42 avg price